
Patricia L Morris
Examiner (ID: 4560, Phone: (571)272-0688 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1203, 1612, 1201, 1625, 1209 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16389503
[patent_doc_number] => 20200330444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => DEUTERATED COMPOUNDS FOR TREATING PAIN AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/214222
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/214222 | DEUTERATED COMPOUNDS FOR TREATING PAIN AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF | Jun 29, 2017 | Abandoned |
Array
(
[id] => 14501085
[patent_doc_number] => 20190194197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => NEW PROCESSES FOR THE PREPARATION OF VEMURAFENIB
[patent_app_type] => utility
[patent_app_number] => 16/313597
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313597 | Processes for the preparation of Vemurafenib | Jun 29, 2017 | Issued |
Array
(
[id] => 11991630
[patent_doc_number] => 20170295786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'PROCESSES FOR THE PREPARATION OF PESTICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/636774
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4999
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636774 | PROCESSES FOR THE PREPARATION OF PESTICIDAL COMPOUNDS | Jun 28, 2017 | Abandoned |
Array
(
[id] => 16343491
[patent_doc_number] => 20200308141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/313502
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313502 | SOLID STATE FORMS OF NERATINIB AND SALTS THEREOF | Jun 26, 2017 | Abandoned |
Array
(
[id] => 15848049
[patent_doc_number] => 10639284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Immunomodulator compounds
[patent_app_type] => utility
[patent_app_number] => 15/633569
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31975
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 632
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15633569
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/633569 | Immunomodulator compounds | Jun 25, 2017 | Issued |
Array
(
[id] => 14581149
[patent_doc_number] => 20190218183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR
[patent_app_type] => utility
[patent_app_number] => 16/311502
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311502 | Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor | Jun 22, 2017 | Issued |
Array
(
[id] => 16842861
[patent_doc_number] => 11014935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Compounds for the treatment of paramyxovirus viral infections
[patent_app_type] => utility
[patent_app_number] => 15/627757
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93581
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627757
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627757 | Compounds for the treatment of paramyxovirus viral infections | Jun 19, 2017 | Issued |
Array
(
[id] => 15556729
[patent_doc_number] => 20200062776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => HEDGEHOG ACYLTRANSFERASE INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/310356
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310356 | HEDGEHOG ACYLTRANSFERASE INHIBITORS AND USES THEREOF | Jun 15, 2017 | Abandoned |
Array
(
[id] => 14198841
[patent_doc_number] => 10266513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Bruton's tyrosine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/624969
[patent_app_country] => US
[patent_app_date] => 2017-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56453
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624969
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/624969 | Bruton's tyrosine kinase inhibitors | Jun 15, 2017 | Issued |
Array
(
[id] => 11979240
[patent_doc_number] => 20170283394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE'
[patent_app_type] => utility
[patent_app_number] => 15/623550
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5060
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15623550
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/623550 | Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone | Jun 14, 2017 | Issued |
Array
(
[id] => 14485039
[patent_doc_number] => 10329286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => FXR (NR1H4) modulating compounds
[patent_app_type] => utility
[patent_app_number] => 15/619675
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16306
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15619675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/619675 | FXR (NR1H4) modulating compounds | Jun 11, 2017 | Issued |
Array
(
[id] => 14962969
[patent_doc_number] => 20190308962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => FXR (NR1H4) Modulating Compounds
[patent_app_type] => utility
[patent_app_number] => 16/308915
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308915 | FXR (NR1H4) Modulating Compounds | Jun 8, 2017 | Abandoned |
Array
(
[id] => 15696709
[patent_doc_number] => 10604521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/310163
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 4521
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310163
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310163 | Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof | Jun 8, 2017 | Issued |
Array
(
[id] => 11969808
[patent_doc_number] => 20170273962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'Inhibitors of Hepatitis C Virus Polymerase'
[patent_app_type] => utility
[patent_app_number] => 15/618418
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55363
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618418 | Inhibitors of hepatitis C virus polymerase | Jun 8, 2017 | Issued |
Array
(
[id] => 11969151
[patent_doc_number] => 20170273303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'MACROCYCLIC PICOLINAMIDES AS FUNGICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/617741
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39097
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617741 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | Jun 7, 2017 | Abandoned |
Array
(
[id] => 14246061
[patent_doc_number] => 10273222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/616319
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35281
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/616319 | Histone demethylase inhibitors | Jun 6, 2017 | Issued |
Array
(
[id] => 15799985
[patent_doc_number] => 20200123135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => PHARMACEUTICALLY ACCEPTABLE SALT AS RENAL OUTER MEDULLARY POTASSIUM CHANNEL INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/305644
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305644 | Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor | Jun 5, 2017 | Issued |
Array
(
[id] => 11969152
[patent_doc_number] => 20170273306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'MACROCYCLIC PICOLINAMIDES AS FUNGICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/615272
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27741
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/615272 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | Jun 5, 2017 | Abandoned |
Array
(
[id] => 14867917
[patent_doc_number] => 20190284200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 16/307830
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307830
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307830 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | Jun 4, 2017 | Abandoned |
Array
(
[id] => 13106743
[patent_doc_number] => 10072004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
[patent_app_type] => utility
[patent_app_number] => 15/611150
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 58
[patent_no_of_words] => 45765
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15611150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/611150 | Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide | May 31, 2017 | Issued |